Literature DB >> 8525612

Early phase in the infection of cultured cells with papillomavirus virions.

J Zhou1, L Gissmann, H Zentgraf, H Müller, M Picken, M Müller.   

Abstract

The fate of full bovine papillomavirus (BPV) virions and virus-like particles after binding to C127 or CV-1 cells was studied by electron microscopy and indirect immunofluorescence. After incubation at 4 degrees for 1 hr, BPV virions were found to be bound to the plasma membrane, and most viruses were absorbed by the cells after 30 min incubation at 37 degrees. Ninety minutes after the virions had been bound to the plasma membrane, the uptake of the virions was completed and most of the antigen was found to be localized in the nucleus. The viruses were transported in phagosomes and the uptake and transportation could be inhibited by cytochalasin B and taxol, suggesting the possible involvement of microfilaments and microtubules in the virus particle uptake and transportation. The capsid proteins could be detected for about 14 hr, until degradation and deposit of the viral antigen in the Golgi complexes. Although binding to the plasma membrane and uptake of virions into large cytoplasmic vesicles could be monitored by electron microscopy, no complete virions were observed in the nucleus of infected cells despite a very strong nuclear fluorescent staining for both L1 and L2 proteins. This may indicate that disintegration of the virions occurs in the cytoplasm and the L1/L2 proteins migrate to the nucleus via their nuclear localization signals.

Entities:  

Mesh:

Year:  1995        PMID: 8525612     DOI: 10.1006/viro.1995.9943

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei.

Authors:  Z Richterová; D Liebl; M Horák; Z Palková; J Stokrová; P Hozák; J Korb; J Forstová
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

2.  Identification of the alpha6 integrin as a candidate receptor for papillomaviruses.

Authors:  M Evander; I H Frazer; E Payne; Y M Qi; K Hengst; N A McMillan
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription.

Authors:  Michelle A Ozbun
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation.

Authors:  S Sanlioglu; P K Benson; J Yang; E M Atkinson; T Reynolds; J F Engelhardt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding.

Authors:  Alyson Fay; William H Yutzy; Richard B S Roden; Junona Moroianu
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.

Authors:  Nicole A Patterson; Jessica L Smith; Michelle A Ozbun
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells.

Authors:  Latifa Bousarghin; Antoine Touzé; Pierre-Yves Sizaret; Pierre Coursaget
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation.

Authors:  E Payne; M R Bowles; A Don; J F Hancock; N A McMillan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Cell penetration and trafficking of polyomavirus.

Authors:  Joanna M Gilbert; Ilya G Goldberg; Thomas L Benjamin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  Intracellular trafficking pathway of BK Virus in human renal proximal tubular epithelial cells.

Authors:  Takahito Moriyama; Andrey Sorokin
Journal:  Virology       Date:  2007-10-31       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.